Form 4: Progyny CEO Peter Anevski Reports Stock and Option Grants

Peter Anevski, CEO of Progyny, Inc., reports the acquisition of restricted stock units and stock options as part of an annual merit grant.

Summary

• Peter Anevski, the CEO of Progyny, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• On March 3, 2025, Anevski acquired 127,272 shares of common stock underlying restricted stock units (RSUs) and 174,239 stock options as part of an annual merit grant under the company's 2019 Equity Incentive Plan.
• The RSUs and stock options vest over three years, with 33% vesting on the first anniversary of the grant date and the remainder vesting quarterly thereafter, contingent upon continued service.
• Anevski also acquired 922 shares of common stock under the company's 2019 Employee Stock Purchase Plan on January 31, 2025.
• Following these transactions, Anevski directly owns 563,495 shares of Progyny common stock and indirectly owns shares through PECO ANEVSKI 2020 SD LLC.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. It's a neutral to slightly positive signal.

Positives

• The grant of RSUs and stock options to the CEO aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.
• Participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the Reporting Person's continued service.

Industry Context

Equity grants are a common practice in the technology and healthcare industries to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation components for CEOs in publicly traded companies, particularly in growth-oriented sectors like healthcare technology.
• Companies like Teladoc Health and Livongo Health (prior to its acquisition by Teladoc) have used similar equity-based compensation plans to align executive incentives with shareholder value creation.
• The vesting schedules are also typical, with multi-year vesting periods designed to promote long-term commitment.

Stakeholder Impact

• The equity grants align management's interests with those of shareholders, potentially driving long-term value creation.
• Employees may view the CEO's equity stake as a positive sign of confidence in the company's future.

Key Dates